CA2615427A1 - Oral contraception with trimegestone - Google Patents

Oral contraception with trimegestone Download PDF

Info

Publication number
CA2615427A1
CA2615427A1 CA002615427A CA2615427A CA2615427A1 CA 2615427 A1 CA2615427 A1 CA 2615427A1 CA 002615427 A CA002615427 A CA 002615427A CA 2615427 A CA2615427 A CA 2615427A CA 2615427 A1 CA2615427 A1 CA 2615427A1
Authority
CA
Canada
Prior art keywords
ethinyloestradiol
trimegestone
dose
combination
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002615427A
Other languages
English (en)
French (fr)
Inventor
Oliver Gloger
Heinrich Kugelmann
Maria Popova
Tamara Pfaff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Oliver Gloger
Heinrich Kugelmann
Maria Popova
Gruenenthal Gmbh
Tamara Pfaff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005034498A external-priority patent/DE102005034498A1/de
Application filed by Oliver Gloger, Heinrich Kugelmann, Maria Popova, Gruenenthal Gmbh, Tamara Pfaff filed Critical Oliver Gloger
Publication of CA2615427A1 publication Critical patent/CA2615427A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
CA002615427A 2005-07-20 2006-07-19 Oral contraception with trimegestone Abandoned CA2615427A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102005034498A DE102005034498A1 (de) 2005-07-20 2005-07-20 Orale Kontrazeption mit Trimegeston
DE102005034498.4 2005-07-20
US11/348,545 2006-02-06
US11/348,545 US20070021396A1 (en) 2005-07-20 2006-02-06 Oral contraception with trimegestone
PCT/EP2006/007103 WO2007009769A1 (en) 2005-07-20 2006-07-19 Oral contraception with trimegestone

Publications (1)

Publication Number Publication Date
CA2615427A1 true CA2615427A1 (en) 2007-01-25

Family

ID=37075980

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002615427A Abandoned CA2615427A1 (en) 2005-07-20 2006-07-19 Oral contraception with trimegestone

Country Status (6)

Country Link
EP (1) EP1909799A1 (es)
KR (1) KR20080031435A (es)
AR (1) AR056674A1 (es)
AU (1) AU2006271920A1 (es)
CA (1) CA2615427A1 (es)
WO (1) WO2007009769A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant

Also Published As

Publication number Publication date
AU2006271920A1 (en) 2007-01-25
KR20080031435A (ko) 2008-04-08
WO2007009769A1 (en) 2007-01-25
AR056674A1 (es) 2007-10-17
EP1909799A1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
US20070021396A1 (en) Oral contraception with trimegestone
US9375437B2 (en) Progesterone containing oral dosage forms and kits
EP1380301B1 (en) Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive
RU2479306C2 (ru) Фармацевтическая композиция, содержащая тетрагидрофолиевую кислоту
US20060058272A1 (en) Pharmaceutical composition for use as a contraceptive
US9084796B2 (en) Hormonal composition and its use
US9278072B2 (en) Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate
JP5484646B2 (ja) 新規な避妊薬とその調製方法
JP2001516720A (ja) プロゲスチン/エストロゲンからなる第一相とプロゲスチンからなる第二相とを有する経口避妊薬製剤
CA2615427A1 (en) Oral contraception with trimegestone
KR20240040774A (ko) 프로게스토겐만을 이용한 경구 피임법
MXPA99000801A (es) Metodo contraceptivo monofasico y estuche que contiene una combinacion de una progestina y estrogeno
MXPA99000883A (es) Contraceptivo oral

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130719